Ganjapreneur reports
The U.S. Food and Drug Administration has denied two applications from companies seeking to sell CBD hemp extracts as a dietary supplement because CBD is an approved drug.
The U.S. Food and Drug Administration (FDA) has denied two applications from companies seeking to sell CBD hemp extracts as a dietary supplement, Fortune reports. The agency said it rejected the applications because CBD is an approved drug and, therefore, excluded from the definition of a dietary supplement and that both applications failed to show that the extract meets the “reasonably expected to be safe under the conditions of use.”
The applicants were Charlotte’s Web Holdings Inc. and Irwin Naturals.
Read the full story at
